Literature DB >> 20975748

Bringing SOD1 into the fold.

Sami Barmada, Steven Finkbeiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20975748     DOI： 10.1038/nn1110-1303

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  15 in total

1.  Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.

Authors:  R J Ferrante; S E Browne; L A Shinobu; A C Bowling; M J Baik; U MacGarvey; N W Kowall; R H Brown; M F Beal
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

Review 2.  Fast intra-axonal transport: Beginning, development and post-genome advances.

Authors:  Annica B Dahlstrom
Journal:  Prog Neurobiol       Date:  2009-12-14       Impact factor: 11.685

Review 3.  ALS: a disease of motor neurons and their nonneuronal neighbors.

Authors:  Séverine Boillée; Christine Vande Velde; Don W Cleveland
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

4.  Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.

Authors:  Jason Miller; Montserrat Arrasate; Benjamin A Shaby; Siddhartha Mitra; Eliezer Masliah; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

Review 5.  The genetic epidemiology of neurodegenerative disease.

Authors:  Lars Bertram; Rudolph E Tanzi
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

Review 6.  Motor neurons rely on motor proteins.

Authors:  Erika L F Holzbaur
Journal:  Trends Cell Biol       Date:  2004-05       Impact factor: 20.808

Review 7.  The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS).

Authors:  Michael J Strong
Journal:  J Neurol Sci       Date:  2009-10-18       Impact factor: 3.181

8.  Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient.

Authors:  Steven J Shook; Erik P Pioro
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

9.  Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.

Authors:  Daryl A Bosco; Gerardo Morfini; N Murat Karabacak; Yuyu Song; Francois Gros-Louis; Piera Pasinelli; Holly Goolsby; Benjamin A Fontaine; Nathan Lemay; Diane McKenna-Yasek; Matthew P Frosch; Jeffrey N Agar; Jean-Pierre Julien; Scott T Brady; Robert H Brown
Journal:  Nat Neurosci       Date:  2010-10-17       Impact factor: 24.884

10.  Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.

Authors:  M Tortarolo; P Veglianese; N Calvaresi; A Botturi; C Rossi; A Giorgini; A Migheli; C Bendotti
Journal:  Mol Cell Neurosci       Date:  2003-06       Impact factor: 4.314
View more
  2 in total

1.  Cu, Zn-superoxide dismutase 1 (SOD1) is a novel target of Puromycin-sensitive aminopeptidase (PSA/NPEPPS): PSA/NPEPPS is a possible modifier of amyotrophic lateral sclerosis.

Authors:  Guijie Ren; Zhongcai Ma; Maria Hui; Lili C Kudo; Koon-Sea Hui; Stanislav L Karsten
Journal:  Mol Neurodegener       Date:  2011-05-07       Impact factor: 14.195

2.  Cupric ions induce the oxidation and trigger the aggregation of human superoxide dismutase 1.

Authors:  Cheng Li; Wen-Chang Xu; Zhen-Sheng Xie; Kai Pan; Jiao Hu; Jie Chen; Dai-Wen Pang; Fu-Quan Yang; Yi Liang
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.